Cite
HARVARD Citation
Matthews, J. et al. (n.d.). BRIGATINIB SHOWS PRECLINICAL PROMISE FOR AGGRESSIVE RELAPSED/REFRACTORY AK = LK-POSITIVE ALCL. Leukemia research. pp. S16-S17. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Matthews, J. et al. (n.d.). BRIGATINIB SHOWS PRECLINICAL PROMISE FOR AGGRESSIVE RELAPSED/REFRACTORY AK = LK-POSITIVE ALCL. Leukemia research. pp. S16-S17. [Online].